GENinCode plc
Company Profile
Company website
Sector
Medical Equipment and Services (Medical Services)
Description
GENinCode plc (AIM: GENI) is engaged in the risk
assessment, prediction and prevention of cardiovascular disease (“CVD”).
CVD is the leading cause of death worldwide accounting for approximately
18 million deaths annually.
Investor Access
10
Jun
Event information
Matthew Walls, Chief Executive Officer, and Paul Foulger, Chief Financial Officer, will provide a live presentation relating to the results via the Investor Meet Company platform on Wednesday, 10 June at 11am BST.
The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via the Investor Meet Company dashboard until 9am the day before the meeting or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and add to meet GENinCode here.
Venue
Online
Time
Wednesday 10 June at 11.00am BST
Financial Calendar
| Event | Date |
| Year End | December 31 |
| Half Year End | 30 June |
| Preliminary Results | 08 June |
| Interim Results* | September |
| AGM* | June |
* Months based on previous announcements of this kind
